MANHASSET, NY – The Feinstein Institute for Medical Research Professor Bruce Volpe, MD, was recognized this week at a luncheon as a Heritage Healthcare Innovation Award finalist. The award was presented by Heritage Provider Network (HPN) and Crain’s Custom Studio, a division of Crain’s New York Business, to recognize Dr. Volpe’s research using technology to restore limb movement after neurological injury.
Dr. Volpe’s lab examines the use of non-invasive technology to increase the restoration of arm/hands and leg/ankle movement after neurological injury such as stroke. Along with collaborators at Massachusetts Institute of Technology (MIT), he developed interactive robotic assist devices, which move the paralyzed limb when the patient cannot, and knows not to assist when the patient can power the movement. The robots are currently being used at rehabilitation centers around the world as a tool for therapists to train the impaired limb with a reproducible, high-intensity and engaging challenge to maintain the patient’s motivation and attention.
Dr. Volpe was honored in the Heritage Research Investigators in Translational Medicine category at the Heritage Healthcare Awards, which recognize innovators who have most improved the access to and quality of affordable health care in the communities they serve in the greater New York area.
“It is an honor to be recognized by the greater New York health care community for my team’s research to benefit stroke survivors and other patients with neurological impairment,” said Dr. Volpe. “With the use of technology, we can help patients overcome challenges after stroke and help them bring movement back into their lives.”
To view a video of Dr. Volpe’s rehabilitation robots in action, click here.
To learn more about Dr. Volpe’s research, contact Johanna Chang at 516-562-3646.
About the Feinstein Institute
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.
For media inquiries, please contact:
Heather E. Ball Mayer